Search
for
Sort by
Research 421–450 of 1000+
- Management of Folliculitis Decalvans: A Systematic Review
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- VITILIGO: WHAT’S OLD, WHAT’S NEW?
- Markers of inflammation, metabolic disorders, and principles of treatment for alopecia areata in children
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Efficacy of derinat as a treatment for murine and androgenetic alopecia (AGA) patients
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- A Niche Above: A Novel Modality of Stem Cell Regulation in Mammalian Skin Epidermis
- Medical Therapies
- SnapshotDx Quiz: February 2018
- Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- Prostaglandin E2 prevents radiotherapy-induced alopecia by attenuating transit amplifying cell apoptosis through promoting G1 arrest
- Nucleus‐specific modulation of phasic and tonic inhibition by endogenous neurosteroidogenesis in the murine thalamus
- Alopecia areata – Current understanding and management
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Skin Pigmentation Types, Causes and Treatment—A Review
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Alopecia Areata: An Updated Review for 2023
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Vitiligo - Part 2 - classification, histopathology and treatment
- Hepatocyte growth factor (HGF) activator expressed in hair follicles is involved in in vitro HGF-dependent hair follicle elongation
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention